Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The application of organ-on-chip models for the prediction of human pharmacokinetic profiles during drug development.
Pharmacol Res. 2023 Sep;195:106853. doi: 10.1016/j.phrs.2023.106853. Epub 2023 Jul 18.
Pharmacol Res. 2023.
PMID: 37473876
Free article.
Review.
A Human Renal Proximal Tubule Cell Line with Stable Organic Anion Transporter 1 and 3 Expression Predictive for Antiviral-Induced Toxicity.
Nieskens TT, Peters JG, Schreurs MJ, Smits N, Woestenenk R, Jansen K, van der Made TK, Röring M, Hilgendorf C, Wilmer MJ, Masereeuw R.
Nieskens TT, et al. Among authors: van der made tk.
AAPS J. 2016 Mar;18(2):465-75. doi: 10.1208/s12248-016-9871-8. Epub 2016 Jan 28.
AAPS J. 2016.
PMID: 26821801
Free PMC article.
Item in Clipboard
Are cell-based therapies for kidney disease safe? A systematic review of preclinical evidence.
Mihajlovic M, Wever KE, van der Made TK, de Vries RBM, Hilbrands LB, Masereeuw R.
Mihajlovic M, et al. Among authors: van der made tk.
Pharmacol Ther. 2019 May;197:191-211. doi: 10.1016/j.pharmthera.2019.01.004. Epub 2019 Jan 22.
Pharmacol Ther. 2019.
PMID: 30677474
Free article.
Item in Clipboard
Blood-brain barrier perturbations by uremic toxins: Key contributors in chronic kidney disease-induced neurological disorders?
Faucher Q, van der Made TK, De Lange E, Masereeuw R.
Faucher Q, et al. Among authors: van der made tk.
Eur J Pharm Sci. 2023 Aug 1;187:106462. doi: 10.1016/j.ejps.2023.106462. Epub 2023 May 9.
Eur J Pharm Sci. 2023.
PMID: 37169097
Free article.
Review.
Item in Clipboard
Quantitative Translation of Microfluidic Transporter in Vitro Data to in Vivo Reveals Impaired Albumin-Facilitated Indoxyl Sulfate Secretion in Chronic Kidney Disease.
van der Made TK, Fedecostante M, Scotcher D, Rostami-Hodjegan A, Sastre Toraño J, Middel I, Koster AS, Gerritsen KG, Jankowski V, Jankowski J, Hoenderop JGJ, Masereeuw R, Galetin A.
van der Made TK, et al.
Mol Pharm. 2019 Nov 4;16(11):4551-4562. doi: 10.1021/acs.molpharmaceut.9b00681. Epub 2019 Sep 27.
Mol Pharm. 2019.
PMID: 31525064
Item in Clipboard
Clinical Investigation on Endogenous Biomarkers to Predict Strong OAT-Mediated Drug-Drug Interactions.
Willemin ME, Van Der Made TK, Pijpers I, Dillen L, Kunze A, Jonkers S, Steemans K, Tuytelaars A, Jacobs F, Monshouwer M, Scotcher D, Rostami-Hodjegan A, Galetin A, Snoeys J.
Willemin ME, et al. Among authors: van der made tk.
Clin Pharmacokinet. 2021 Sep;60(9):1187-1199. doi: 10.1007/s40262-021-01004-2. Epub 2021 Apr 10.
Clin Pharmacokinet. 2021.
PMID: 33840062
Clinical Trial.
Item in Clipboard
Correction to: Clinical Investigation on Endogenous Biomarkers to Predict Strong OAT-Mediated Drug-Drug Interactions.
Willemin ME, Van Der Made TK, Pijpers I, Dillen L, Kunze A, Jonkers S, Steemans K, Tuytelaars A, Jacobs F, Monshouwer M, Scotcher D, Rostami-Hodjegan A, Galetin A, Snoeys J.
Willemin ME, et al. Among authors: van der made tk.
Clin Pharmacokinet. 2022 Mar;61(3):463. doi: 10.1007/s40262-022-01109-2.
Clin Pharmacokinet. 2022.
PMID: 35175504
No abstract available.
Item in Clipboard
Cite
Cite